http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-143074-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
| filingDate | 2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e50114adbfa0cd4f5b0fa5bd17e53ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50130ea00634243553e15b7d92614b9f |
| publicationDate | 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MY-143074-A |
| titleOfInvention | Progesteron receptor modulators |
| abstract | THE SUBJECT INVENTION PROVIDES A COMPOUND ACCORDING TO FORMULA 1, WHEREIN IS O, NOH, NO(1-4C)ALKYL, NO(1-4C)ACYL; A1-A5 ARE C, SUBSTITUTED WITH R1, OR N, PROVIDED THAT AT LEAST ONE AND NOT MORE THAN THREE OF A1 -A5 ARE N; OR ONE OR TWO OF A1, A2 AND A5 ARE N, AND THE OTHERS ARE C, SUBSTITUTED WITH R1, AND A3 AND A4 TOGETHER REPRESENT A FUSED BENZO RING OR A FUSED FIVE- OR SIX-MEMBERED NITROGEN-CONTAINING AROMATIC RING, BOTH OPTIONALLY SUBSTITUTED WITH ONE OR MORE HALOGEN AND/OR (1-4C)ALKYL; R1 IS H, HALOGEN, (1 -4C)ALKYL, (1 -4C)ALKOXY; R2 IS H, (1 -4C)ALKYL OR (1 -6C)ALKENYL, BOTH OPTIONALLY SUBSTITUTED WITH AN (6-1 O)ARYL GROUP, WHICH IS OPTIONALLY SUBSTITUTED WITH ONE OR MORE HALOGEN AND/OR (1-4C)ALKYL; AND R3 IS H OR (1-4C)ALKYL, OPTIONALLY SUBSTITUTED WITH ONE OR MORE HALOGEN ATOMS; AND R4 IS CYCLOPROPYL OR CYCLOPROPENYL, BOTH OPTIONALLY SUBSTITUTED WITH ONE OR MORE HALOGEN AND/OR (1 -4C)ALKYL; OR R2 TOGETHER WITH R3 FORMS A 3-, 4-, 5- OR 6- MEMBERED CARBOCYCLIC RING; AND R4 IS CYCLOPROPYL OR CYCLOPROPENYL, BOTH OPTIONALLY SUBSTITUTED WITH ONE OR MORE HALOGEN AND/OR (1 -4C)ALKYL); OR R2 IS H OR (1 -4C)ALKYL; AND R3 TOGETHER WITH R4 FORMS A 5-, 6- OR 7-MEMBERED SATURATED OR UNSATURATED CARBOCYCLIC RING; R5 IS H OR (1 -4C)ALLCYL; OR A PHARMACEUTICALLY ACCEPTABLE SALT AND/OR HYDRATE FORM AND/OR PRODRUG THEREOF. |
| priorityDate | 2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123173 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420193223 |
Total number of triples: 23.